Ardent Health Partners, LLC
ARDT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,577 | $1,645 | $1,497 | $1,606 |
| % Growth | -4.2% | 9.9% | -6.8% | – |
| Cost of Goods Sold | $677 | $271 | $259 | $654 |
| Gross Profit | $900 | $1,375 | $1,238 | $952 |
| % Margin | 57.1% | 83.6% | 82.7% | 59.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $305 | $1,034 | $1,004 | $286 |
| SG&A Expenses | $645 | $1,034 | $1,004 | $616 |
| Sales & Mktg Exp. | $340 | $0 | $0 | $329 |
| Other Operating Expenses | $0 | $203 | $167 | $0 |
| Operating Expenses | $645 | $1,237 | $1,171 | $616 |
| Operating Income | $254 | $137 | $67 | $337 |
| % Margin | 16.1% | 8.3% | 4.5% | 21% |
| Other Income/Exp. Net | -$257 | -$15 | $7 | -$170 |
| Pre-Tax Income | -$2 | $122 | $74 | $167 |
| Tax Expense | -$3 | $26 | $15 | $26 |
| Net Income | -$23 | $73 | $41 | $114 |
| % Margin | -1.5% | 4.4% | 2.8% | 7.1% |
| EPS | -0.17 | 0.52 | 0.3 | 0.8 |
| % Growth | -132.7% | 73.3% | -62.5% | – |
| EPS Diluted | -0.17 | 0.52 | 0.29 | 0.86 |
| Weighted Avg Shares Out | 141 | 140 | 140 | 143 |
| Weighted Avg Shares Out Dil | 141 | 141 | 141 | 133 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $14 | $15 | $14 | $14 |
| Depreciation & Amortization | $39 | $39 | $36 | $38 |
| EBITDA | $56 | $176 | $125 | $195 |
| % Margin | 3.5% | 10.7% | 8.3% | 12.2% |